Study Details
Testing the Study Drug UCB0022 for People with Advanced Parkinsons Disease
(IRB#: IRB_00172303)
Advanced Parkinsons Disease is nerve damage in the brain that affects a persons movement and balance. Advanced Parkinsons Disease is when the symptoms are disabling and affect daily life. This study will test a drug called UCB0022 for people with this condition. The study wants to see if it will help people and is safe. People in the study will be randomly chosen to receive UCB0022 or a placebo while on the standard of care. A placebo looks like the study drug but does not have the treatment. People in the study will use a tablet to complete surveys, wear a special watch, and keep a diary. Being in the study requires attending in-person visits at the study clinic. Participation lasts about 18 weeks. Medical tests will be done to track the health of participants.
- All genders
- Over 18 years old
- Volunteers with special conditions
- In Person
- Paid
Who can participate?
Gender: All genders
Age: Over 18 years old
Volunteers: Volunteers with special conditions
Location: In Person
Inclusion Criteria
- Ages 35 to 80 years old
- Diagnosis of Parkinsons Disease at least 5 years before participation
- Serious daily motor skill issues
- Able to complete a symptoms diary
- Childbearing age participants must use specific birth control
Exclusion Criteria
- Diagnosis of other specific forms of Parkinsons Disease
- Diagnosis of Dementia
- History of alcohol or drug use disorder within the previous 2 years
- History of major depression or other mental health disorder within the previous 5 years that affects study participation
- History of neurosurgery such as surgery of the brain
Will I be paid for my time?
Yes
IRB#: IRB_00172303
PI: Paolo Moretti
Department: NEUROLOGY
Approval Date: 2024-07-31 06:00:00
Study Categories: Brain Health Studies
Specialties: Neurology
I am Interested